Ari M Grinspan

7PUBLICATIONS
49CO-AUTHORS
Medical infection agents (incl. prions)Major global burdens of diseaseMedical bacteriologyVeterinary virologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 02, 2026
15-strain live biotherapeutic product or same donor fecal microbiota transplant for recurrent Clostridioides difficile infection: a randomized phase 1b trial.

|Jun 07, 2021
Epidemiology of community-acquired and recurrent Clostridioides difficile infection.

Yichun Fu, Yuying Luo, Ari M Grinspan

|Mar 22, 2021
Systematic Review with Meta-Analysis: Fecal Microbiota Transplantation for Severe or Fulminant Clostridioides difficile.

Emily N Tixier, Elijah Verheyen, Yuying Luo

|Sep 16, 2020
Gastrointestinal involvement attenuates COVID-19 severity and mortality.

Alexandra E Livanos, Divya Jha, Francesca Cossarini

|Aug 21, 2020
Defined microbiota transplant restores Th17/RORγt+ regulatory T cell balance in mice colonized with inflammatory bowel disease microbiotas.

Graham J Britton, Eduardo J Contijoch, Matthew P Spindler

|Oct 16, 2019
Faecal microbiota transplant decreases mortality in severe and fulminant Clostridioides difficile infection in critically ill patients.

Emily N Tixier, Elijah Verheyen, Ryan C Ungaro

Pageof 2

Frequent Collaborators

3 joint publications

Graham J Britton

2 joint publications

Jean-Frederic Colombel

2 joint publications

Jeremiah J Faith

1 joint publications

Eduardo J Contijoch